1. Home
  2. SSD vs KYMR Comparison

SSD vs KYMR Comparison

Compare SSD & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simpson Manufacturing Company Inc.

SSD

Simpson Manufacturing Company Inc.

N/A

Current Price

$173.73

Market Cap

6.9B

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$74.30

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSD
KYMR
Founded
1956
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SSD
KYMR
Price
$173.73
$74.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
26
Target Price
$206.00
$107.72
AVG Volume (30 Days)
193.0K
615.0K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
0.67%
N/A
EPS Growth
8.42
N/A
EPS
8.24
N/A
Revenue
$2,332,808,000.00
$39,211,000.00
Revenue This Year
$3.82
$11.85
Revenue Next Year
$5.57
$7.79
P/E Ratio
$20.95
N/A
Revenue Growth
4.51
N/A
52 Week Low
$137.35
$19.45
52 Week High
$211.98
$103.00

Technical Indicators

Market Signals
Indicator
SSD
KYMR
Relative Strength Index (RSI) 34.95 35.15
Support Level $163.95 $64.95
Resistance Level $187.60 $77.93
Average True Range (ATR) 4.49 3.66
MACD -1.52 -1.19
Stochastic Oscillator 27.57 5.84

Price Performance

Historical Comparison
SSD
KYMR

About SSD Simpson Manufacturing Company Inc.

Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: